No phaseRecruiting

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

Sponsor
Uromedica (Industry)
Enrolment
167 planned
Conditions
Urinary Incontinence; Urinary Incontinence,Stress
Interventions
Adjustable Continence Therapy for Women (ACT)
Ages
adults, older adults
Registry
NCT04248283

Full record on ClinicalTrials.gov

From the registry

A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.

Primary outcomes

  • Provocative pad weight

History

  1. Study completion expected

  2. Primary completion expected

  3. Last registry update

  4. Started

  5. Registered